Report Shows Prescription Opioid Use in US Declined by 60% From 2011 Peak
December 17th 2020Decreases in prescription opioid volume over the past 9 years have been driven by changes in clinical use, regulatory, and reimbursement policies, and in progressively more restrictive legislation enacted since 2012.
Read More
Margetuximab-cmkb Approved by FDA With Chemotherapy for Metastatic HER2-Positive Breast Cancer
December 17th 2020FDA approves margetuximab-cmkb (Margenza) in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have previously received 2 or more anti-HER2 regimens.
Read More
Zooming Through the Pandemic: NSU Virtual AMCP Student Chapter
There are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Read More
Understanding the 340B Prime Vendor Program and Supporting Stakeholders During COVID-19
December 15th 2020Under the 340B Prime Vendor Program, the Prime Vendor has several functions that it carries out to support stakeholders in operating and navigate the field so that they can effectively achieve lower 340B drug pricing for those who need it most.
Read More
New Research Analyzes Quality of Life for Caregivers of Persons with Traumatic Brain Injury
December 14th 2020The papers in the special issue highlight the research team’s focus on understanding the experiences of caregivers of persons with TBI and illustrate the team’s ability to efficiently capture those experiences through a tool known as TBI-CareQOL Measurement System.
Read More